Literature DB >> 8626374

Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction.

A Kaptein1, V Paillard, M Saunders.   

Abstract

Interleukin-6 (IL-6) induces tyrosine phosphorylation and activation of the latent transcription factor Stat3 in HepG2 cells. Mutation of Stat3 tyrosine 705 to phenylalanine (Y705F) inhibits IL-6-induced tyrosine phosphorylation of this Stat3 mutant in transfected HepG2 cells. In cotransfections of HepG2 cells, the Stat3 mutant Y705F causes a reduction of the tyrosine phosphorylation of wild type Stat3-FLAG. Moreover, Y705F inhibits the action of endogenous Stat3 in cotransfected cells, reducing IL-6 induction of a Stat3-responsive reporter construct. Y705F therefore acts as a dominant negative mutation of Stat3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626374     DOI: 10.1074/jbc.271.11.5961

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  98 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

2.  Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma.

Authors:  D Sampath; M Castro; D C Look; M J Holtzman
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

4.  Fyn promotes Th17 differentiation by regulating the kinetics of RORγt and Foxp3 expression.

Authors:  Aki Ueda; Liang Zhou; Paul L Stein
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

5.  Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.

Authors:  Amir Sonnenblick; Carmit Levy; Ehud Razin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 6.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.

Authors:  Matthew R Farren; Louise M Carlson; Colleen S Netherby; Inna Lindner; Pui-Kai Li; Dmitry I Gabrilovich; Scott I Abrams; Kelvin P Lee
Journal:  Sci Signal       Date:  2014-02-18       Impact factor: 8.192

8.  Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.

Authors:  T Mikita; D Campbell; P Wu; K Williamson; U Schindler
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 9.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

10.  Crif1 is a novel transcriptional coactivator of STAT3.

Authors:  Min-chul Kwon; Bon-Kyoung Koo; Jin-Sook Moon; Yoon-Young Kim; Ki Cheol Park; Nam-Shik Kim; Mi Yi Kwon; Myung-Phil Kong; Ki-Jun Yoon; Sun-Kyoung Im; Jaewang Ghim; Yong-Mahn Han; Sung Key Jang; Minho Shong; Young-Yun Kong
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.